Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 54.60
+0.10 (0.18%)
Apr 17, 2026, 1:30 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.88 billion as of April 17, 2026. Its market cap has increased by 28.31% in one year.
Market Cap
4.88B
Enterprise Value
4.13B
Revenue
1.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.60
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.88B, a decrease of -28.35%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.88B | 24.37% |
| Dec 31, 2025 | 3.92B | 1.15% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.79B |
| Steminent Biotherapeutics | 5.69B |
| Panion & Bf Biotech | 5.57B |
| UnicoCell Biomed | 5.15B |
| OBI Pharma | 4.98B |
| Pharmosa Biopharm | 4.83B |
| Formosa Pharmaceuticals | 4.79B |
| Medigen Biotechnology | 4.37B |